Recent Advances in the Rationale Design of GPER Ligands

E-ISSN： 1875-533x|19|36|6199-6206

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.36, 2012-12, pp. : 6199-6206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Dimerization - Rationale for the Design of Bivalent Ligands

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 343-345

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the development of melanocortin-4 receptor ligands

By Nozawa Dai Chaki Shigeyuki Nakazato Atsuro

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 403-427

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 5, 2002-10 ,pp. : 507-517

Bentham Science Publishers

Access to resources Recommend Favorite

Advances and Challenges in Drug Design of PPARδ Ligands

Current Drug Targets, Vol. 19, Iss. 2, 2018-01 ,pp. : 144-154

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Selective μ-Opioid Ligands as Evaluated in Animal Models

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 1, 2006-03 ,pp. : 1-14

Bentham Science Publishers

Access to resources Recommend Favorite